Objective: To study the surgical treatment for primary liver cancer with the first clinical menifestation of obstructive jaundice (Icteric Type Hepa-tocellular Carcinoma, IHCC).

The existing severe obstructive jaundice has been universally recognized as a potential risk factor which is associated with high peri-operative mortality and morbidity.

Effect of reactive oxygen species in inducing hepatic apoptosis in rats with obstructive jaundice;

Value of magnetic resonance Fast Acquired Multi.Phase Enhanced Fast GRE for low-strain water drinking in diagnosing the obstructive jaundice;

Preoperative and postoperative treatment in patients with obstructive jaundice with malignant obstructive jaundice and postoperative complication;

Proper timing of definitive surgery in malignant obstructive jaundice after biliary decompression;

Metallic biliary stent insertion combined with interventional chemotherapy in treatment of malignant obstructive jaundice;

Palliative treatment of malignant obstructive jaundice with drainage within T-tube bridging the bile duct and the duodenum;

Oral ferric ammonium citrate solution in MRCP for diagnosing low-level obstructive jaundice;